The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Trusitev SR 4 mg Prolonged-release Capsules, hard

4 milligram(s) Prolonged-release capsule

Teva Pharma B.V.PA0749/191/002

Main Information

Trade NameTrusitev SR 4 mg Prolonged-release Capsules, hard
Active SubstancesTolterodine tartrate
Strength4 milligram(s)
Dosage FormProlonged-release capsule
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/191/002

Group Information

ATC CodeG04BD Drugs for urinary frequency and incontinence
G04BD07 tolterodine


Licence Issued16/11/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0025-008-032
Interchangeable List DocumentPDF of Interchangeable List
« Back